NCT02101398

Brief Summary

The aim of this work is to study the effect of transcranial direct current stimulation combined with naming therapy in acute and post-acute stroke comparing four bihemispheric positioning electrodes to a sham condition.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2014

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 2, 2014

Completed
6 months until next milestone

Study Start

First participant enrolled

October 2, 2014

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2021

Enrollment Period

1.7 years

First QC Date

March 21, 2014

Last Update Submit

August 28, 2025

Conditions

Keywords

tDCSStrokeAphasiaNaming

Outcome Measures

Primary Outcomes (1)

  • Percentage of improvement of picture naming

    Before stimulation and immediately after stimulation

Study Arms (5)

F7A

EXPERIMENTAL

Anodal electrode set on the left Broca's area and cathodal electrode set on its right homologue. Active stimulation.

Device: eldith DC-stimulator, configuration F7A

F7C

EXPERIMENTAL

Cathodal electrode set on the left Broca's area and anodal electrode set on its right homologue. Active stimulation.

Device: eldith DC-stimulator, configuration F7C

T5A

EXPERIMENTAL

Anodal electrode set on the left Wernicke's area and cathodal electrode set on its right homologue. Active stimulation.

Device: eldith DC-stimulator, configuration T5A

T5C

EXPERIMENTAL

Cathodal electrode set on the left Wernicke's area and anodal electrode set on its right homologue. Active stimulation.

Device: eldith DC-stimulator, configuration T5C

Sham

SHAM COMPARATOR

Electrodes set on the left Broca's area and its right homologue or electrodes set on the left Wernicke's area and its right homologue, but no stimulation will be delivered.

Device: eldith DC-stimulator, configuration Sham

Interventions

tDCS will be delivered during a 20 minutes speech-language therapy session

F7A

tDCS will be delivered during a 20 minutes speech-language therapy session

F7C

tDCS will be delivered during a 20 minutes speech-language therapy session

T5A

tDCS will be delivered during a 20 minutes speech-language therapy session

T5C

Sham tDCS will be delivered during a 20 minutes speech-language therapy session

Sham

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • man or woman of 18 years and older
  • aphasic patient following a first left hemispheric stroke
  • BDAE 3.0 aphasia score \> or = to 1
  • mother tongue = French
  • right handedness
  • signed informed consent

You may not qualify if:

  • history of other neurologic pathologies
  • dementia
  • bilingual patient (2 mother tongues)
  • history of cranial surgery
  • presence of intracerebral metallic material
  • pregnant, parturient or lactating woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Raymond Poincaré

Garches, 92380, France

Location

MeSH Terms

Conditions

AphasiaStroke

Condition Hierarchy (Ancestors)

Speech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Nicolas ROCHE, MD

    Hôpital Raymond Poincaré

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2014

First Posted

April 2, 2014

Study Start

October 2, 2014

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

September 4, 2025

Record last verified: 2021-08

Locations